Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT04554199 Completed - Clinical trials for Missing Posterior Occlusal Contact

Brain and Cognitive Function of Patients With RPD

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

To evaluate the influence of restoring lost posterior occlusal contacts with removable partial denture (RPD) on the brain activity and cognitive function in controlled type 2 diabetic patients

NCT ID: NCT04553900 Completed - Hyperthermia Clinical Trials

Effect of Heat Stress on Global LV Function in Anesthetized Humans

Start date: June 9, 2017
Phase: N/A
Study type: Interventional

Recent data suggests that increased temperature improves inotropic function during systole and may improve diastolic function in healthy humans at rest, despite a reduction in left ventricular volume at end diastole. The effect of heat stress has not been reported in patients receiving general anesthesia and the impact of general anesthesia on these findings is not known. Trans-esophageal echocardiography will be used to measure parameters important to both systolic and diastolic function at temperature intervals of 1°C in patients undergoing "Heated Intraoperative Peritoneal Chemotherapy" (HIPEC.) That general anesthesia will not alter the cardiovascular effects of increased temperature that has been reported in healthy, un-anesthetized humans is the hypothesis.

NCT ID: NCT04553731 Completed - Clinical trials for Overweight and Obese Pregnant Women

The Effects of mHealth Intervention on Health Empower of Overweight and Obese Women's Body Weight During Pregnancy

Start date: January 1, 2020
Phase: N/A
Study type: Interventional

evaluate the health empowerment program with mHealth to promote physical activity for overweight and obese pregnant women.

NCT ID: NCT04553549 Completed - Stroke, Acute Clinical Trials

Safety and Feasibility of the Infinity Catheter for Radial Access

Start date: October 1, 2020
Phase:
Study type: Observational

The main objective of this single arm study is to evaluate the safety and feasibility of the AXS Infinity LS (Stryker, Freemont, CA, USA) and AXS Infinity LS Plus (Stryker, Freemont, CA, USA) catheters during the transradial approach through a secondary use of the data collected during neurointerventional procedures. This includes evaluating the conversion rates to a transfemoral approach. A secondary aim of the study is to assess the radial artery occlusion rates post procedure.

NCT ID: NCT04553497 Completed - Clinical trials for Interferential Current in Proximal Humerus Fractures

IFC Therapy in Proximal Humerus Fractures

Start date: April 1, 2014
Phase: N/A
Study type: Interventional

Proximal humerus fractures (PHFs) frequently occur in the elderly and osteoporotic population, but these fractures are also common in individuals under age 60 years. Conservative treatment of PHF usually involves a short period of immobilization followed by orthopedic rehabilitation. However, the severe pain of some patients with fractures limits their participation in the exercise programme, and shoulder muscle atrophy and frozen shoulder may occur in these patients due to immobilization. There are conflicting results regarding the use of physical therapy modalities in the shoulder pain management. Interferential current (IFC) therapy is believed to be effective for the pain-relieving through several mechanisms. Although IFC has been investigated in many painful shoulder disorders, there is no reported study on the effectiveness of IFC therapy in patients with PHF. This study aimed to investigate the effectiveness of IFC added to exercise on shoulder function, pain, and disability compared with placebo in patients with conservative treated PHF. Patients were evaluated within the first week of PHF and divided into two groups to receive either IFC or sham using a simple randomization method. The orthopedic rehabilitation programme was applied to all patients three times a week for four weeks under the guidance of the same physiotherapist. IFC or sham therapy was applied three times a week for 20 minutes before each exercise session by another physiotherapist. Shoulder functions, pain (visual analogue scale), disability and range of motion was evaluated at the end of the rehabilitation program, at 6-weeks and 18-weeks post-treatment by the physiatrist (ED) who did not know which group the patients belonged to. In addition, the amount of acetaminophen usage was noted at each visit.

NCT ID: NCT04553159 Completed - Safety Clinical Trials

Autologous Adipose Derived Stem Cells Transplantation in the Treatment of Keloids.

Start date: March 1, 2021
Phase: Phase 2
Study type: Interventional

Keloids are the most common disfiguring skin disorder affecting colored population with a prevalence of upto 16%. Autologous adipose derived stem cells have been found to have potential therapeutic benefits however limited clinical trials have compared there role to standard therapy. This is a pilot study that is intended to evaluate the feasibility of conducting this clinical trial comparing adipose derived stromal vascular fraction to Triamcinolone in keloid treatment. The full clinical trial is already registered under the clinical trial number NCT04391621. The objective of this Pilot is to evaluate the feasibility of conducting a full study on the same topic.

NCT ID: NCT04552535 Completed - Clinical trials for Squamous Non-small Cell Lung Cancer

A Study in the United States Using Electronic Medical Records (EMR) to Assess Effectiveness of Afatinib (Gilotrif) Following Pembrolizumab and Chemotherapy in the Treatment of Metastatic Squamous Cell Carcinoma of the Lung

Start date: May 8, 2020
Phase:
Study type: Observational

This study aims to characterize the profile and outcomes for patients with Squamous Cell Carcinoma of the Lung (SqCC) who progress on 1L pembrolizumab in combination with platinum based chemotherapy and receive afatinib as second line (2L) therapy.

NCT ID: NCT04552431 Completed - Clinical trials for Chronic Prostatitis With Chronic Pelvic Pain Syndrome

Chronic Prostatitis Collaborative Research Network Clinical Trial- Ciprofloxacin and Tamsulosin

CPCRN RCT1
Start date: September 30, 1997
Phase: Phase 2
Study type: Interventional

Although the cause of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is unknown, physicians sometimes try to treat it with antibiotics or alpha-receptor blockers. In this multicenter, double-blind factorial trial, 196 men with moderately severe CP/CPPS were randomly assigned to 6 weeks of treatment with ciprofloxacin, tamsulosin, both drugs, or placebo. Neither ciprofloxacin nor tamsulosin substantively reduced symptoms. Ciprofloxacin and tamsulosin were not effective treatments for CP/CPPS. Patients had long-standing, refractory CP/CPPS and received trial treatments for only 6 weeks. Patients with new diagnoses who are given longer courses of the trial treatments might respond differently.

NCT ID: NCT04552405 Completed - Clinical trials for Familial Adenomatous Polyposis (FAP)

Preventive Anti-inflammatory Diet to Reduce Gastro-intestinal Inflammation in FAP Patients: a Prospective Pilot Study

FAPPER
Start date: September 12, 2017
Phase: N/A
Study type: Interventional

Preventive anti-inflammatory diet to reduce gastro-intestinal inflammation in FAP patients: a prospective pilot study

NCT ID: NCT04552132 Completed - Clinical trials for Apical Periodontitis

Postoperative Pain and Healing in Teeth Treated With GentleWave or EndoActivator

Start date: September 30, 2020
Phase: N/A
Study type: Interventional

Patients with painful molars will be randomly assigned to 2 different groups: GentleWave and EndoActivator. The root canals will be completed using identical protocols except in the mode of delivery and activation of irrigation (using either the GentleWave or EndoActivator). Postoperative pain and pain pill consumption will be measured for the 4 days following their root canal using a Visual Analog Scale and Pain Pill Log, respectively. The alternative hypothesis is that patients undergoing treatment using the GentleWave will experience less pain postoperatively and will consume fewer pain pills. A 12-month follow up with exam and radiographs will be completed to evaluate healing.